ABSTRACT
Every MS patient is different, and prescribing the correct treatment based on MS disease characteristics and patientrelated factors (comorbidities, desire for children, etc) is no trivial matter. Anticipating potential complications associated with each disease-modifying therapy and taking the correct action before adverse events occur is a major challenge facing MS neurologists.In this first of a two-part ParadigMS series, Professors Maura Pugliatti and Carlo Pozzilli will share with you their strategies for identifying treatment risks based on individual patient characteristics....
ABSTRACT
No two MS patients are the same, and yet only a limited number of disease-modifying therapies are available for MS neurologists to treat their patients. In this second of a two-part series, Professors Maura Pugliatti and Carlo Pozzilli expand on their earlier presentation (Risk in Multiple Sclerosis Treatment) to guide you in how to manage and mitigate risks associated with treating MS patients. They follow a multifaceted approach based on their own experience and literature reports to provide a set of key messages underlying risk mitigation in MS treatment.
MAURA PUGLIATTI
Maura...
30th June 2022, Seventh ParadigMS Symposium
During the Seventh Belgian ParadigMS Symposium, Prof Celia Oreja-Guevara and Prof Veronica Popescu had a workshop on MRI & OCT.
24 April 2021, Expert meeting. Professors Grigoriadis and Boyko gave an update on the role of the microbiome in multiple sclerosis. They discuss the function of the microbiome, its importance in the health of the individual, and how its dysregulation is implicated in altered immune responses in MS. Consult here the slide deck.
24 April 2021, Expert meeting. : How is an MS patient’s disease likely to progress over time? Will the patient be stable on a first-line therapy, or will the disease progress quickly if not treated aggressively? Professors Bart Van Wijmeersch and Celia Oreja-Guevara share with you their wealth of experience concerning patient prognosis.
24 April 2021, Expert meeting: In this slide deck Mona Alkhawajah and Carlo Pozzilli discuss the history of telemedicine and how innovative approaches are being developed to care for MS patients in this post-COVID world in which we now live.
Minimum two MS experts collaborate to produce an educational slide deck. These slide decks are presented (live) to ParadigMS members, peer reviewed and updated. The slide decks are published on the ParadigMS website “on behalf of ParadigMS”.
Consensus publications
Based on the slide decks, publications are produced. These publications are peer reviewed and published as consensus publications.
Regional and national educational events
Regional (fe: Scandinavian countries, Benelux, …) or national events where state-of-the-art science is transferred to general neurologists and other care givers (nurses, etc) that are confronted with MS in their day to day practice.
Web-based educational tools and resources
Webinars can complement the educational events.
Medical education (ME) programs
The educational slide decks, events and webinars can be important building blocks of accredited educational programs.
Your subscription will automatically renew on a monthly or yearly basis, depending on the plan you have chosen. If you cancel your plan, it will not renew at the end of your subscription cycle. It will end once the period you have paid for is over.
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, you will be banned immediately from the community and could be liable to prosecution.
You can cancel your trial or subscription in your account settings. If you cancel during the trial period you will not be charged.
Terms and Conditions
All the Terms and Conditions of the ParadigMS Foundation Website can be downloaded here.
Subscribe to our bi-annual Newsletter
ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)